Carlos Curbelo bought Jazz Pharmaceuticals PLC (NASDAQ: JAZZ)
Carlos Curbelo (R-FL), a U.S. Representative, has disclosed 1 trade in Jazz Pharmaceuticals PLC (JAZZ) since 2018, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Carlos Curbelo bought $1,001 - $15,000 of Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) on August 28, 2018. Since that trade, JAZZ is up +50.59% against the S&P 500 up +183.46%, an outperformance of -132.87%.
Data updated
Carlos Curbelo's JAZZ trades vs the price
JAZZ is up +50.59% since Carlos Curbelo bought on August 28, 2018, versus +183.46% for the S&P 500.
Performance since this trade
All Carlos Curbelo JAZZ trades
Carlos Curbelo & JAZZ trading FAQ
Is it legal for Carlos Curbelo to trade Jazz Pharmaceuticals PLC (JAZZ) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Jazz Pharmaceuticals PLC (JAZZ), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Carlos Curbelo buy JAZZ?
Carlos Curbelo disclosed a purchase of $1,001 - $15,000 of Jazz Pharmaceuticals PLC (JAZZ) on August 28, 2018, according to public STOCK Act filings.
How has JAZZ performed since Carlos Curbelo's trade?
Since Carlos Curbelo bought JAZZ on August 28, 2018, the stock is up +50.59%, versus +183.46% for the S&P 500 over the same period, an outperformance of -132.87%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional JAZZ trades?
Quantellect tracks every disclosed congressional trade in Jazz Pharmaceuticals PLC (JAZZ) on the Jazz Pharmaceuticals PLC congressional trading page, which aggregates filings across all members of Congress.
Carlos Curbelo's JAZZ tradesAll congressional filings for Jazz Pharmaceuticals PLCCarlos Curbelo's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.